Ball Bearings From Japan and the United Kingdom, 798-799 [2010-33355]
Download as PDF
<![CDATA[
798
Federal Register / Vol. 76, No. 4 / Thursday, January 6, 2011 / Notices
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All nonconfidential
written submissions will be available for
public inspection at the Office of the
Secretary.
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of sections 201.10 and 210.50(a)(4)
of the Commission’s Rules of Practice
and Procedure (19 CFR 201.10,
210.50(a)(4)).
Issued: December 30, 2010.
By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 2010–33356 Filed 1–5–11; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation Nos. 731–TA–394–A & 399–
A (Second Review) (Fourth Remand)]
Ball Bearings From Japan and the
United Kingdom
United States International
Trade Commission.
ACTION: Notice of remand proceedings.
AGENCY:
The U.S. International Trade
Commission (‘‘Commission’’) hereby
gives notice of its fourth remand
proceeding with respect to its
affirmative determination in the fiveyear review of the antidumping duty
order on ball bearings from Japan. For
further information concerning the
conduct of this proceeding and rules of
general application, consult the
Commission’s Rules of Practice and
Procedure, part 201, subparts A through
E (19 CFR part 201), and part 207,
subpart A (19 CFR part 207).
DATES: Effective Date: December 30,
2010.
FOR FURTHER INFORMATION CONTACT:
James McClure, Office of Investigations,
telephone 202–205–3191, or David
Goldfine, Office of General Counsel,
telephone 202–708–5452, U.S.
International Trade Commission, 500 E
Street, SW., Washington, DC 20436.
Hearing-impaired persons can obtain
information on this matter by contacting
the Commission’s TDD terminal on 202–
205–1810. Persons with mobility
impairments who will need special
assistance in gaining access to the
erowe on DSK5CLS3C1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
15:07 Jan 05, 2011
Jkt 223001
Commission should contact the Office
of the Secretary at 202–205–2000.
General information concerning the
Commission may also be obtained by
accessing its Internet server (https://
www.usitc.gov).
SUPPLEMENTARY INFORMATION:
Background.—On December 9, 2010,
the Court of International Trade (per
Judge Barzilay) issued an opinion in
NSK Corp. et al. v. United States, Slip
Op. 10–133 (‘‘NSK V’’). In that opinion,
the Court has again affirmed-in-part and
remanded-in-part the Commission’s
determinations in Certain Bearings and
Parts Thereof from Japan and the
United Kingdom, Inv. Nos. 731–TA–
394–A & 399–A (Second Review) (Third
Remand), USITC Pub. 4194 (Aug. 2010).
In NSK V, the Court affirmed the
Commission’s determination not to
cumulate subject imports from the
United Kingdom because they would
not likely have a discernible adverse
impact. NSK V at 4–6. The Court also
affirmed the Commission’s negative
determination with respect to the
United Kingdom. Id. at 6.
As to the remaining issues with
respect to the cumulated subject imports
from France, Germany, Italy, and Japan,
the Court again affirmed the
Commission’s findings that the
cumulated imports would likely have
significant volume and price effects. Id.
at 7. Nevertheless, with respect to the
likely impact by cumulated subject
imports, the Court again remanded the
issue to the Commission. Id. at 8–12.
Under the remand schedule ordered
by the Court, the Commission was
required to file a status report with the
Court on December 20, 2010, advising
the Court as to whether it would be reopening the record on the likely impact
issue. The Court also directed the
parties to submit a proposed joint
scheduling order for the fourth remand
proceedings.
On December 20, 2010, the
Commission filed the requested status
report with the Court, advising the
Court that it will not be re-opening the
record. On December 20, 2010, the
parties also submitted a proposed joint
scheduling order. On December 22,
2010, the Court approved the proposed
scheduling order and directed the
Commission to file its fourth remand
determination by March 1, 2011. Under
the remand schedule ordered by the
Court, Plaintiffs, Plaintiff-Intervenors,
and Defendant-Intervenors may file
their comments with the Court
regarding the Commission’s fourth
remand determination by April 1, 2011.
Participation in the proceeding.—
Only those persons who were interested
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
parties to the reviews (i.e., persons
listed on the Commission Secretary’s
service list) and parties to the appeal
may participate in the remand
proceeding. Such persons need not
make any additional filings with the
Commission to participate in the
remand proceeding, unless they are
adding new individuals to the list of
persons entitled to receive business
proprietary information under
administrative protective order.
Business proprietary information (‘‘BPI’’)
referred to during the remand
proceeding will be governed, as
appropriate, by the administrative
protective order issued in the reviews.
Written submissions.—The
Commission is not re-opening the
record in this remand proceeding. The
Commission will permit the parties to
file comments pertaining to the specific
issues that are the subject of the Court’s
remand instructions. Comments should
be limited to no more than fifteen (15)
double-spaced and single-sided pages of
textual material. No appendices or other
attachments are allowed. The parties
may not themselves submit any new
factual information in their comments
and may not address any issue other
than those that are the subject of the
Court’s remand instructions. Any such
comments must be filed with the
Commission no later than January 14,
2011.
All written submissions must conform
with the provisions of section 201.8 of
the Commission’s rules; any
submissions that contain BPI must also
conform with the requirements of
sections 201.6, 207.3, and 207.7 of the
Commission’s rules. The Commission’s
rules do not authorize filing of
submissions with the Secretary by
facsimile or electronic means, except to
the extent permitted by section 201.8 of
the Commission’s rules, as amended, 67
Fed. Reg. 68036 (Nov. 8, 2002).
In accordance with sections 201.16(c)
and 207.3 of the Commission’s rules,
each document filed by a party to the
investigation must be served on all other
parties to the investigation (as identified
by either the public or BPI service list),
and a certificate of service must be
timely filed. The Secretary will not
accept a document for filing without a
certificate of service.
Parties are also advised to consult
with the Commission’s Rules of Practice
and Procedure, part 201, subparts A
through E (19 CFR part 201), and part
207, subpart A (19 CFR part 207) for
provisions of general applicability
concerning written submissions to the
Commission.
By order of the Commission.
E:\FR\FM\06JAN1.SGM
06JAN1
Federal Register / Vol. 76, No. 4 / Thursday, January 6, 2011 / Notices
Issued: December 30, 2010.
Marilyn R. Abbott,
Secretary to the Commission.
Drug
Sufentanil (9740) ..........................
[FR Doc. 2010–33355 Filed 1–5–11; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated June 17, 2010, and
published in the Federal Register on
June 28, 2010, 75 FR 36680, United
States Pharmacopeial Convention,
12601 Twinbrook Parkway, Rockville,
Maryland 20852, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the following basic
classes of controlled substances:
Drug
Schedule
Cathinone (1235) ..........................
Methaqualone (2565) ...................
Lysergic acid diethylamide (7315)
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
4-Methyl-2,5dimethoxyamphetamine (7395).
3,4-Methylenedioxyamphetamine
(7400).
Codeine-n-oxide (9053) ................
Heroin (9200) ...............................
Amphetamine (1100) ....................
Drug
erowe on DSK5CLS3C1PROD with NOTICES
I
The company plans to import
reference standards for sale to
researchers and analytical labs.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
United States Pharmacopeial
Convention to import the basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. DEA has
investigated United States
Pharmacopeial Convention to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: December 23, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
I
I
II
Dated: December 23, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–11 Filed 1–5–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
[FR Doc. 2011–12 Filed 1–5–11; 8:45 am]
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
BILLING CODE 4410–09–P
Employee Benefits Security
Administration
DEPARTMENT OF JUSTICE
Publication of Year 2010 Form M–1
With Electronic Filing Option, Notice
Drug Enforcement Administration
Morphine (9300) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Alfentanil (9737) ...........................
By Notice dated October 15, 2010, and
published in the Federal Register on
October 26, 2010, 75 FR 65660,
Noramco Inc., 1440 Olympic Drive,
Athens, Georgia 30601, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the
following basic classes of controlled
substances:
Drug
Schedule
Thebaine (9333) .........................
Tapentadol (9780) ......................
II
II
II
II
II
The company plans to import
Thebaine (9333) analytical reference
standards for distribution to its
customers. The company plans to
Jkt 223001
Employee Benefits Security
Administration, Department of Labor.
ACTION: Notice on the Availability of the
Year 2010 Form M–1 with Electronic
Filing Option.
AGENCY:
Importer of Controlled Substances;
Notice of Registration
Schedule
Drug
15:07 Jan 05, 2011
I
I
I
I
I
I
II
import an intermediate form of
Tapentadol (9780) to bulk manufacture
Tapentadol for distribution to its
customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Noramco Inc. to import the basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. DEA has
investigated Noramco Inc. to ensure that
the company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Schedule
Methamphetamine (1105) ............
Phenmetrazine (1631) ..................
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Glutethimide (2550) ......................
Phencyclidine (7471) ....................
Alphaprodine (9010) .....................
Anileridine (9020) .........................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Diphenoxylate (9170) ...................
Hydrocodone (9193) .....................
Levorphanol (9220) ......................
Meperidine (9230) ........................
Methadone (9250) ........................
Dextropropoxyphene, bulk (nondosage forms) (9273).
VerDate Mar<15>2010
Schedule
799
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
II
II
This document announces the
availability of the Year 2010 Form M–
1, Annual Report for Multiple Employer
Welfare Arrangements and Certain
Entities Claiming Exception. It is
generally identical to the 2009 Form M–
1, except that a few changes were made
to update the Part 7 compliance
questions to reflect the current
provisions of Part 7 that were effective
in 2010. The Form M–1 may again be
filed electronically over the Internet.
FOR FURTHER INFORMATION CONTACT: For
inquiries regarding the Form M–1 filing
requirement, contact Amy J. Turner or
Beth L. Baum, Office of Health Plan
Standards and Compliance Assistance,
SUMMARY:
E:\FR\FM\06JAN1.SGM
06JAN1
]]>Agencies
[Federal Register Volume 76, Number 4 (Thursday, January 6, 2011)]
[Notices]
[Pages 798-799]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-33355]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation Nos. 731-TA-394-A & 399-A (Second Review) (Fourth
Remand)]
Ball Bearings From Japan and the United Kingdom
AGENCY: United States International Trade Commission.
ACTION: Notice of remand proceedings.
-----------------------------------------------------------------------
SUMMARY: The U.S. International Trade Commission (``Commission'')
hereby gives notice of its fourth remand proceeding with respect to its
affirmative determination in the five-year review of the antidumping
duty order on ball bearings from Japan. For further information
concerning the conduct of this proceeding and rules of general
application, consult the Commission's Rules of Practice and Procedure,
part 201, subparts A through E (19 CFR part 201), and part 207, subpart
A (19 CFR part 207).
DATES: Effective Date: December 30, 2010.
FOR FURTHER INFORMATION CONTACT: James McClure, Office of
Investigations, telephone 202-205-3191, or David Goldfine, Office of
General Counsel, telephone 202-708-5452, U.S. International Trade
Commission, 500 E Street, SW., Washington, DC 20436. Hearing-impaired
persons can obtain information on this matter by contacting the
Commission's TDD terminal on 202-205-1810. Persons with mobility
impairments who will need special assistance in gaining access to the
Commission should contact the Office of the Secretary at 202-205-2000.
General information concerning the Commission may also be obtained by
accessing its Internet server (https://www.usitc.gov).
SUPPLEMENTARY INFORMATION:
Background.--On December 9, 2010, the Court of International Trade
(per Judge Barzilay) issued an opinion in NSK Corp. et al. v. United
States, Slip Op. 10-133 (``NSK V''). In that opinion, the Court has
again affirmed-in-part and remanded-in-part the Commission's
determinations in Certain Bearings and Parts Thereof from Japan and the
United Kingdom, Inv. Nos. 731-TA-394-A & 399-A (Second Review) (Third
Remand), USITC Pub. 4194 (Aug. 2010). In NSK V, the Court affirmed the
Commission's determination not to cumulate subject imports from the
United Kingdom because they would not likely have a discernible adverse
impact. NSK V at 4-6. The Court also affirmed the Commission's negative
determination with respect to the United Kingdom. Id. at 6.
As to the remaining issues with respect to the cumulated subject
imports from France, Germany, Italy, and Japan, the Court again
affirmed the Commission's findings that the cumulated imports would
likely have significant volume and price effects. Id. at 7.
Nevertheless, with respect to the likely impact by cumulated subject
imports, the Court again remanded the issue to the Commission. Id. at
8-12.
Under the remand schedule ordered by the Court, the Commission was
required to file a status report with the Court on December 20, 2010,
advising the Court as to whether it would be re-opening the record on
the likely impact issue. The Court also directed the parties to submit
a proposed joint scheduling order for the fourth remand proceedings.
On December 20, 2010, the Commission filed the requested status
report with the Court, advising the Court that it will not be re-
opening the record. On December 20, 2010, the parties also submitted a
proposed joint scheduling order. On December 22, 2010, the Court
approved the proposed scheduling order and directed the Commission to
file its fourth remand determination by March 1, 2011. Under the remand
schedule ordered by the Court, Plaintiffs, Plaintiff-Intervenors, and
Defendant-Intervenors may file their comments with the Court regarding
the Commission's fourth remand determination by April 1, 2011.
Participation in the proceeding.--Only those persons who were
interested parties to the reviews (i.e., persons listed on the
Commission Secretary's service list) and parties to the appeal may
participate in the remand proceeding. Such persons need not make any
additional filings with the Commission to participate in the remand
proceeding, unless they are adding new individuals to the list of
persons entitled to receive business proprietary information under
administrative protective order. Business proprietary information
(``BPI'') referred to during the remand proceeding will be governed, as
appropriate, by the administrative protective order issued in the
reviews.
Written submissions.--The Commission is not re-opening the record
in this remand proceeding. The Commission will permit the parties to
file comments pertaining to the specific issues that are the subject of
the Court's remand instructions. Comments should be limited to no more
than fifteen (15) double-spaced and single-sided pages of textual
material. No appendices or other attachments are allowed. The parties
may not themselves submit any new factual information in their comments
and may not address any issue other than those that are the subject of
the Court's remand instructions. Any such comments must be filed with
the Commission no later than January 14, 2011.
All written submissions must conform with the provisions of section
201.8 of the Commission's rules; any submissions that contain BPI must
also conform with the requirements of sections 201.6, 207.3, and 207.7
of the Commission's rules. The Commission's rules do not authorize
filing of submissions with the Secretary by facsimile or electronic
means, except to the extent permitted by section 201.8 of the
Commission's rules, as amended, 67 Fed. Reg. 68036 (Nov. 8, 2002).
In accordance with sections 201.16(c) and 207.3 of the Commission's
rules, each document filed by a party to the investigation must be
served on all other parties to the investigation (as identified by
either the public or BPI service list), and a certificate of service
must be timely filed. The Secretary will not accept a document for
filing without a certificate of service.
Parties are also advised to consult with the Commission's Rules of
Practice and Procedure, part 201, subparts A through E (19 CFR part
201), and part 207, subpart A (19 CFR part 207) for provisions of
general applicability concerning written submissions to the Commission.
By order of the Commission.
[[Page 799]]
Issued: December 30, 2010.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 2010-33355 Filed 1-5-11; 8:45 am]
BILLING CODE 7020-02-P
